The amendments, which are effective Sept. 25, aim to ensure there’s a level playing field between Canada and the U.S.
Award-winning paper examines whether firm-specific return variation is indicative of more informative stock prices
Regulator says disciplinary measures weren’t severe enough to deter repeat violations
Canaccord’s research team now includes nine senior healthcare analysts across three continents
Omnichannel blurs the line between bricks and mortar retailing and online retailing
Regulator says independent analyst had undisclosed financial interests in some of the companies that she covered
Winning team headed to regional final in Denver
The firm has agreed to continue co-operating with the New York attorney general’s insider trading investigation
11 stocks selected by the firm’s Canadian equity analysts
All investors — large and small — should have access to equal information from listed companies, ASIC says